LGMD2A clinical trials at University of California Health
1 research study open to eligible people
Showing trials for
LGMD R1 Natural History Study
open to eligible people ages 12-50
This is a 24-month, observational study of 100 participants with Limb Girdle Muscular Dystrophy type R1, also known as CAPN3.
at UC Irvine
Our lead scientists for LGMD2A research studies include Tahseen Mozaffar, MD.
Last updated: